skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
NONE
Issue Dt:
Application #:
12597046
Filing Dt:
09/23/2011
Publication #:
Pub Dt:
01/12/2012
Inventor:
George R. Painter
Title:
"Methods of Reducing Nephrotoxicity in Subjects Administered Nucleoside Phosphonates"
Assignment: 1
Reel/Frame:
023772/0551Recorded: 01/13/2010Pages: 5
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
01/05/2010
Assignee:
2505 MERIDIAN PARKWAY
SUITE 340
DURHAM, NORTH CAROLINA 27713
Correspondent:
MBSS / MARTHENN SALAZAR
4140 PARKLAKE AVE
SUITE 600
RALEIGH, NC 27612
Assignment: 2
Reel/Frame:
061720/0982Recorded: 11/10/2022Pages: 13
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
09/24/2022
Assignee:
300 PROFESSIONAL DR.
GAITHERSBURG, MARYLAND 20879
Correspondent:
STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
1100 NEW YORK AVENUE, NW
WASHINGTON, DC 20005
Assignment: 3
Reel/Frame:
062054/0526Recorded: 12/04/2022Pages: 13
Conveyance:
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE: EMERGENT BIODEFENSE OPERATIONS LANSING LLC 3500 MARTIN LUTHER KING JR. BLVD, LANSING, MICHIGAN 48906 PREVIOUSLY RECORDED AT REEL: 061720 FRAME: 0982. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT.
Assignor:
Exec Dt:
09/24/2022
Assignee:
3500 N MARTIN LUTHER KING JR. BLVD.
LANSING, MICHIGAN 48906
Correspondent:
STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
1100 NEW YORK AVENUE, NW
WASHINGTON, DC 20005

Search Results as of: 04/29/2024 06:47 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT